Cargando…

Plasma metabolites mediate the effect of HbA1c on incident cardiovascular disease

BACKGROUND: We aim to discover whether HbA1c affects incident cardiovascular disease (CVD) through regulating endogenous metabolites. METHODS AND RESULTS: Totally, 2019 plasma samples were analyzed by liquid chromatography‐quadrupole time‐of‐flight mass spectrometry. Logistic regression and linear r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Xuesi, Zhou, Wei, Li, Hu, Fan, Yuanming, Yin, Xiaojian, Li, Yong, Chen, Feng, Ma, Gaoxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2019
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788485/ https://www.ncbi.nlm.nih.gov/pubmed/31361035 http://dx.doi.org/10.1002/clc.23243

Ejemplares similares

Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes
por: Matsutani, Daisuke, et al.
Publicado: (2018)

Fasting plasma glucose variability and HbA1c are associated with peripheral artery disease risk in type 2 diabetes
por: Yang, Chun-Pai, et al.
Publicado: (2020)

The relationship between HbA(1c) and ultrasound plaque textures in atherosclerotic patients
por: Huang, Xiao-Wei, et al.
Publicado: (2016)

HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target
por: Ceriello, Antonio, et al.
Publicado: (2022)

HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients
por: Su, Jian-bin, et al.
Publicado: (2018)

Glycemic Profiles of Healthy Individuals with Low Fasting Plasma Glucose and HbA1c
por: Nomura, Kyoko, et al.
Publicado: (2011)

HbA1c below 7 % as the goal of glucose control fails to maximize the cardiovascular benefits: a meta-analysis
por: Wang, Pin, et al.
Publicado: (2015)

HbA(1c) measurement and relationship to incident stroke
por: Robson, R., et al.
Publicado: (2016)

Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial
por: Ceriello, Antonio, et al.
Publicado: (2020)

Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients
por: Sia, Ching-Hui, et al.
Publicado: (2021)

The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease
por: Bots, Sophie H., et al.
Publicado: (2016)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus
por: Gu, Jun, et al.
Publicado: (2018)

Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China
por: Hu, Chengping, et al.
Publicado: (2020)

HbA1c, Coronary atheroma progression and cardiovascular outcomes
por: Dykun, Iryna, et al.
Publicado: (2022)

Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting
por: Kassaian, Seyed Ebrahim, et al.
Publicado: (2012)

Association of plasma PCB levels and HbA1c concentration in Iran
por: Eftekhari, Sahar, et al.
Publicado: (2018)

Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c
por: Sun, Bao, et al.
Publicado: (2022)

HbA(1c): The lower the better?
por: Araki, Eiichi, et al.
Publicado: (2011)

Comparison of oral glucose tolerance test and HbA1c in detection of disorders of glucose metabolism in patients with acute stroke
por: Matz, Karl, et al.
Publicado: (2020)

The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009)

Haemoglobin J-Baltimore can be detected by HbA(1c) electropherogram but with underestimated HbA(1c) value
por: Brunel, Valéry, et al.
Publicado: (2016)

Performance of HbA(1c) and Fasting Plasma Glucose in Screening for Diabetes in Patients Undergoing Coronary Angiography
por: Wang, Jun-Sing, et al.
Publicado: (2013)

HbA(1c) versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients
por: Hjellestad, Iren D, et al.
Publicado: (2013)

Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes
por: Yang, Chen-Yi, et al.
Publicado: (2020)

Prevalence of Diabetes and Prediabetes according to Fasting Plasma Glucose and HbA1c
por: Jeon, Ja Young, et al.
Publicado: (2013)

Association of HbA1c and cardiovascular and renal disease in an adult Mediterranean population
por: Hernandez, Domingo, et al.
Publicado: (2013)

Influence of Serum Albumin on HbA1c and HbA1c-Defined Glycemic Status: A Retrospective Study
por: Feng, Xiaojing, et al.
Publicado: (2021)

Standardization of the HbA(2) Assay
por: Paleari, Renata, et al.
Publicado: (2018)

Screening for diabetes with HbA1c: Test performance of HbA1c compared to fasting plasma glucose among Chinese, Malay and Indian community residents in Singapore
por: Lim, Wei-Yen, et al.
Publicado: (2018)

Are the Same Clinical Risk Factors Relevant for Incident Diabetes Defined by Treatment, Fasting Plasma Glucose, and HbA(1c)?
por: Balkau, Beverley, et al.
Publicado: (2011)

Fluctuations in HbA1c are associated with a higher incidence of cardiovascular disease in Japanese patients with type 2 diabetes
por: Bouchi, Ryotaro, et al.
Publicado: (2011)

Hemoglobin variants detected by hemoglobin A1c (HbA1c) analysis and the effects on HbA1c measurements
por: Nasir, Nadzimah Mohd, et al.
Publicado: (2010)

HbA(1c) for Diabetes Screening in Acute Coronary Syndrome: time for a reappraisal of the guidelines?
por: McCune, C, et al.
Publicado: (2015)

Drugs affecting HbA1c levels
por: Unnikrishnan, Ranjit, et al.
Publicado: (2012)

Current Status of HbA1c Biosensors
por: Lin, Hua, et al.
Publicado: (2017)

Visit-to-visit HbA(1c) variability is associated with in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention
por: Yang, Chen Die, et al.
Publicado: (2020)

Validation and feasibility of a postal system for remote monitoring of HbA1c
por: Cross, Jen, et al.
Publicado: (2021)

Inpatient HbA1c testing: a prospective observational study
por: Nanayakkara, Natalie, et al.
Publicado: (2015)

HbA(1c) and the Prediction of Type 2 Diabetes in Children and Adults
por: Vijayakumar, Pavithra, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ufpa7uinakviic2c2ob1tl0d6g